| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fate Therapeutics Inc (FATE) has 13 insiders with recent SEC Form 4 filings, including 1 buy and 62 sells. FATE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.89M | $8.31M | - | |
| CEO | 1.30M | $2.78M | - | |
| Other | 400.0K | $854.0K | - | |
| Dir | 110.0K | $234.8K | - | |
| CFO | 100.0K | $213.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 15, 2021 | Valamehr Bahram87 | Chief Development Officer | Sale+OE | 25,000 | $92.35 | $2,308,772.18 | -4.6% | -3.0% | -66.2% | |
| Mar 8, 2021 | Shoemaker Daniel D | Chief Scientific Officer | Sell | 25,000 | $81.74 | $2,043,428.24 | -3.7% | - | - | |
| Feb 18, 2021 | Wolchko J Scott87 | President And CEO | Sale+OE | 20,000 | $102.01 | $2,040,258.22 | -1.0% | - | - | |
| Jan 22, 2021 | Wolchko J Scott87 | President And CEO | Sale+OE | 60,000 | $100.67 | $6,039,968.30 | -1.2% | - | - | |
| Jan 19, 2021 | Tahl Cindy79 | General Counsel And Secretary | Sale+OE | 35,000 | $114.76 | $4,016,639.28 | -8.4% | - | - | |
| Jan 11, 2021 | Valamehr Bahram87 | Chief Development Officer | Sell | 9,484 | $114.95 | $1,090,139.84 | -1.7% | - | - | |
| Jan 11, 2021 | Wolchko J Scott87 | President And CEO | Sell | 69,407 | $116.33 | $8,073,772.22 | -2.7% | - | - | |
| Jan 11, 2021 | Tahl Cindy79 | General Counsel And Secretary | Sell | 9,483 | $114.94 | $1,090,021.13 | -1.4% | - | - | |
| Jan 11, 2021 | Shoemaker Daniel D | Chief Scientific Officer | Sell | 9,482 | $114.95 | $1,089,911.48 | -1.5% | - | - | |
| Jan 8, 2021 | Redmile Group, LLC | Director, 10% Owner | Buy | 327,485 | $85.50 | $27,999,967.50 | +2.6% | - | - |